Showing results (81-90 of 201) with videos related to

Sort By:
Pageof 21
Food Research International (Ottawa, Ont.)|March 28, 2018
Degradation of β-casomorphins and identification of degradation products during yoghurt processing using liquid chromatography coupled with high resolution mass spectrometryDuc Doan Nguyen, Francesco Busetti, Stuart Keith Johnson, et al.
Neurology|February 13, 2018
Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumabEnchi Liu, Dai Wang, Reisa Sperling, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 29, 2016
Challenges, solutions, and recommendations for Alzheimer's disease combination therapyJames A Hendrix, Randall J Bateman, H Robert Brashear, et al.
Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2016
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summitJosé L Molinuevo, Jordi Cami, Xavier Carné, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's diseaseEric Siemers, Todd Feaster, Gopalan Sethuraman, et al.
Thorax|June 25, 2011
Use of non-invasive haemodynamic measurements to detect treatment response in precapillary pulmonary hypertensionWai-Ting Nicola Lee, Aileen Brown, Andrew John Peacock, et al.
MRS Advances|September 17, 2021
Recent progress in acoustic field-assisted 3D-printing of functional composite materialsKeith Johnson, Drew Melchert, Daniel S Gianola, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Nature Medicine|May 6, 2024
APOE4 homozygozity represents a distinct genetic form of Alzheimer's diseaseJuan Fortea, Jordi Pegueroles, Daniel Alcolea, et al.
Pageof 21